SPOP and posterior cortical atrophy: A multicenter retrospective study involving 131 patients with PCa found that speckle-type POZ protein (SPOP) gene mutations are critical predictors of a favorable treatment response to PARP inhibitors; however, the underlying mechanism is unclear (5).